PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1446671-0	1992	Synthetic peptides as antagonists of the anaphylatoxin C3a.	Peptides	10-18	complement C3	Homo sapiens	55-58	
12871936-7	2003	This variant efficiently mobilizes calcium in response to synthetic C3a agonist peptides, but not to native C3a.	Peptides	80-88	complement C3	Homo sapiens	68-71	
25982307-3	2015	Cp40, a second-generation compstatin analog in clinical development, is a 14 amino-acid cyclic peptide that selectively inhibits complement activation in humans and non-human primates by binding to C3 and C3b.	Peptides	95-102	complement C3	Homo sapiens	205-208	
1756717-12	1991	Phosphoamino acid analysis of the synthetic peptides indicated that serine 71 of C3a was phosphorylated by LPK-1.	Peptides	44-52	complement C3	Homo sapiens	81-84	
6139373-10	1983	A tryptic peptide containing the 3H label was isolated following digestion of [3H]C3b on activated thiol-Sepharose.	Peptides	10-17	complement C3	Homo sapiens	82-85	
1572104-2	1992	The biological activities of the anaphylatoxin C3a and synthetic C3a analogue peptides were determined in both assays.	Peptides	78-86	complement C3	Homo sapiens	65-68	
1466288-1	1992	The human saliva of normal subjects containing large amounts of basic carboxypeptidase produces decarboxylated non inflammatory peptides, for instance, kinins and anaphilotoxins C3a, C4a and C5a.	Peptides	128-136	complement C3	Homo sapiens	178-181	
3486674-3	1986	Longer synthetic C3a analogue peptides, e.g., C3a-57-77 containing the 21 COOH-terminal amino acids, exhibit activity nearly equivalent to that of intact C3a.	Peptides	30-38	complement C3	Homo sapiens	17-20	
3486674-3	1986	Longer synthetic C3a analogue peptides, e.g., C3a-57-77 containing the 21 COOH-terminal amino acids, exhibit activity nearly equivalent to that of intact C3a.	Peptides	30-38	complement C3	Homo sapiens	46-49	
3486674-3	1986	Longer synthetic C3a analogue peptides, e.g., C3a-57-77 containing the 21 COOH-terminal amino acids, exhibit activity nearly equivalent to that of intact C3a.	Peptides	30-38	complement C3	Homo sapiens	46-49	
6333413-4	1984	Studies reported here demonstrate that the spasmogenic action of C3a on guinea pig parenchymal lung tissue is mimicked by synthetic peptides based on the carboxy-terminal sequence of C3a.	Peptides	132-140	complement C3	Homo sapiens	65-68	
6333413-4	1984	Studies reported here demonstrate that the spasmogenic action of C3a on guinea pig parenchymal lung tissue is mimicked by synthetic peptides based on the carboxy-terminal sequence of C3a.	Peptides	132-140	complement C3	Homo sapiens	183-186	
6333413-5	1984	Synthetic peptides with sequences corresponding to the 5, 8, 13 and 21 carboxy-terminal residues of C3a all possess spasmogenic activity on lung tissue.	Peptides	10-18	complement C3	Homo sapiens	100-103	
6333413-8	1984	A 21 residue peptide, C3a 57-77, exhibits activity equivalent to native C3a.	Peptides	13-20	complement C3	Homo sapiens	22-25	
6333413-8	1984	A 21 residue peptide, C3a 57-77, exhibits activity equivalent to native C3a.	Peptides	13-20	complement C3	Homo sapiens	72-75	
266705-0	1977	Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.	Peptides	10-18	complement C3	Homo sapiens	75-78